Eric Chin
First SEC filing: June 6, 2025 · Latest: June 6, 2025
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 26, 2026 | BMRA | P | 6,250 | $1.60 | $10,000 | 38,750 Direct | +19.23% | Acquired | 28.1% (price as of 2026-10-05) |
| Dec. 12, 2025 | BMRA | A | 22,500 | · | · | 32,500 Direct | +225.00% | Acquired | (price as of 2026-10-05) |
| March 31, 2022 | ASTH | F | 469 | $48.47 | $22,732 | 20,844 Direct | -2.20% | Disposed | -24.1% (price as of 2026-10-05) |
| Feb. 3, 2022 | ASTH | F | 2,802 | $50.71 | $142,089 | 21,313 Direct | -11.62% | Disposed | -27.4% (price as of 2026-10-05) |
| March 31, 2021 | ASTH | F | 555 | $27.09 | $15,035 | 24,115 Direct | -2.25% | Disposed | 35.9% (price as of 2026-10-05) |
| March 8, 2021 | ASTH | A | 8,606 | · | · | 24,670 Direct | +53.57% | Acquired | (price as of 2026-10-05) |
| Feb. 3, 2021 | ASTH | A | 6,867 | · | · | 16,064 Direct | +74.67% | Acquired | (price as of 2026-10-05) |
| Feb. 3, 2021 | ASTH | A | 3,103 | · | · | 3,103 Direct | · | Acquired | (price as of 2026-10-05) |
| June 11, 2020 | ASTH | P | 2,040 | $14.90 | $30,396 | 9,197 Direct | +28.50% | Acquired | 147.0% (price as of 2026-10-05) |
| March 31, 2020 | ASTH | F | 555 | $12.92 | $7,171 | 7,157 Direct | -7.20% | Disposed | 184.9% (price as of 2026-10-05) |
| Feb. 5, 2020 | ASTH | A | 4,073 | · | · | 7,712 Direct | +111.93% | Acquired | (price as of 2026-10-05) |
| Feb. 5, 2020 | ASTH | J | 4,083 | · | · | 3,639 Direct | -52.87% | Disposed | (price as of 2026-10-05) |
| Nov. 27, 2019 | ASTH | A | 4,083 | · | · | 7,722 Direct | +112.20% | Acquired | (price as of 2026-10-05) |
| June 12, 2019 | ASTH | P | 2,040 | $14.72 | $30,029 | 3,639 Direct | +127.58% | Acquired | 150.1% (price as of 2026-10-05) |
| Jan. 30, 2019 | ASTH | A | 1,599 | · | · | 1,599 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 3, 2021 | ASTH | Stock Option (right to buy) | Common Stock | $23.24 | Feb. 2, 2026 | 3,103 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 6, 2025 | BMRA | Restricted Stock [F1] | · | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $139,579 | · | · | · | · | · | $358,912 | $498,491 |
| 2021 | $348,077 | $100,000 | $371,555 | $39,905 | · | · | $63,355 | $922,892 |
| 2020 | $300,000 | · | $74,984 | · | · | · | $18,546 | $393,530 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.